Latest Research

Abu Dhabi’s Strategic Investments in China: Beyond Coffee to Diversification

Abu Dhabi made headlines with a $1 billion investment in Luckin Coffee, a major player…

Ribobio Submits Phase I Clinical Trial Application for siRNA Drug RBD3133 Targeting INHBE to EU

Ribobio Biotechnology Limited (06938.HK) and its subsidiary, Ribocure Pharmaceuticals AB, have successfully submitted an Investigational…

China’s AI Sector Faces Funding Challenges Amid Growing Competition

China's AI sector is rapidly advancing, with Moonshot's Kimi K3 approaching the performance of top…

Track Investment Networks In China

Daily updated data and intelligence about the money and deals moving across Greater China!

Trusted By Global Partners

Extract Investment Insights

Streamed Daily

Since 2011, global funds, equity houses, and research firms have relied on China Money Network's primary data coverage.

Trustworthy

We provide last-mile news coverage of key alternative investment movements in China that you rely on for critical decisions.

Deep Focus

We can decipher the true from the dubious when investment news hits the airwaves, and we translate those discrepancies for you.

QUALITY

Companies like S&P Global, Morgan Stanley, and many others rely on our technology and services to enhance decision making.